BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 443 found
  Current Search:  tab: 443     

HTML
100%
Obamas Electric Moment in Denver
buy tadalafil and online buy tadalafil mg online difference wellbutrin and prozac buy prozac with out a prescription losing the weight aftre stopping prozac generic online propecia soma sniffing paroxetine and weight loss sertraline online...
Oakland Post:  Aug 29 2008 9:57AM
Matching: tab
Find similar documents
HTML
100%
Albemarle To Increase Ibuprofen Prices
Specialty chemicals maker Albemarle Corporation , a leading global manufacturer of the anti-inflammatory agent ibuprofen, will increase the prices for its ibuprofen products $4.50 /kg worldwide, effective October 1, 2008.

The price...

Pharmaceutical Online:  Aug 29 2008 8:05AM
Matching: tab
Find similar documents
HTML
100%
HIV-positive Ivorians to receive free anti-retroviral treatment
Ivorians with HIV/AIDS can now get free anti-retroviral treatment in public health centers with foreign funders picking up much of the tab, according to a decree of which AFP obtained a copy Friday.

HIV-AIDS campaigners march in...

South Asian Womens Forum:  Aug 29 2008 8:14PM
Matching: tab
Find similar documents
HTML
100%
HIV-positive Ivorians to receive free anti-retroviral treatment
ABIDJAN (AFP) - Ivorians with HIV/AIDS can now get free anti-retroviral treatment in public health centers with foreign funders picking up much of the tab, according to a decree of which AFP obtained a copy Friday.

'Antiretroviral...

Yahoo! UK and Ireland:  Aug 29 2008 8:03PM
Matching: tab
Find similar documents
HTML
100%
HIV-positive Ivorians to receive free anti-retroviral treatment
Ivorians with HIV/AIDS can now get free anti-retroviral treatment in public health centers with foreign funders picking up much of the tab, according to a decree of which AFP obtained a copy Friday.

'Antiretroviral treatment is free...

AFP via Yahoo!:  Aug 29 2008 7:18PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc.

(NASDAQ: ALKS - News) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be...

Business Wire via Yahoo!:  Aug 29 2008 2:02PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
Alkermes, Inc.

(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be webcast from the Four Seasons Hotel in Boston...

Genetic Engineering News:  Aug 29 2008 1:14PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alkermes, Inc.

(NASDAQ: ALKS - News) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be...

Yahoo! Canada:  Aug 29 2008 1:03PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
Alkermes, Inc.

(ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be webcast from the Four Seasons Hotel in Boston,...

Houston Chronicle:  Aug 29 2008 1:00PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
Alkermes, Inc.

(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be webcast from the Four Seasons Hotel in Boston...

Forbes.com:  Aug 29 2008 12:56PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas
Alkermes, Inc.

ALKS announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be webcast from the Four Seasons Hotel in Boston,...

Business Wire via MSN Money:  Aug 29 2008 12:42PM
Matching: tab
Find similar documents
HTML
100%
Alkermes' Corporate Presentation to be Webcast at the Thomas Weisel Partners Healthcare Conference
CAMBRIDGE, Mass.

- (Business Wire) Alkermes, Inc.

(NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Thomas Weisel Partners on Friday, September 5, 2008 at 9:45 a.m.

The presentation will be webcast...

Earthtimes.org:  Aug 29 2008 12:41PM
Matching: tab
Find similar documents
HTML
100%
Dr Reddy's gets FDA nod for trandolapril tabs
MUMBAI: Dr Reddy's Laboratories Ltd has received approval from the U.S.

Food and Drug Administration for trandolapril tablets, the regulator's website showed.

Dr Reddy's gets FDA nod for trandolapril tabs.

Economictimes:  Aug 29 2008 5:18AM
Matching: tab
Find similar documents
HTML
100%
Barr Receives Approval for Generic Version of Razadyne(R) Tablets
MONTVALE, N.J., Aug.

28 NJ-Barr-Razadyne-Tabs MONTVALE, N.J., Aug.

28 -- Barr Pharmaceuticals, Inc.

(NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc., received final approval from the U.S.

Food & Drug...

Earthtimes.org:  Aug 28 2008 4:27PM
Matching: tab
Find similar documents
HTML
100%
Illumina to Present at Upcoming Investment Conferences in September
SAN DIEGO-- (BUSINESS WIRE) -- Illumina, Inc.

(NASDAQ:ILMN) today announced that the Company will webcast its presentations at two upcoming investment conferences in September 2008.

Illumina will webcast its presentation at the Thomas...

SmartBrief:  Aug 28 2008 9:03PM
Matching: tab
Find similar documents
HTML
100%
Illumina to Present at Upcoming Investment Conferences in September
- Illumina, Inc.

(NASDAQ:ILMN) today announced that the Company will webcast its presentations at two upcoming investment conferences in September 2008.

Illumina will webcast its presentation at the Thomas Weisel Health Care Conference...

Pharma Live:  Aug 28 2008 11:48AM
Matching: tab
Find similar documents
HTML
100%
Illumina to Present at Upcoming Investment Conferences in September
, 6:00 AM EST News source: Business Wire Illumina, Inc.

(NASDAQ:ILMN) today announced that the Company will webcast its presentations at two upcoming investment conferences in September 2008.

Illumina will webcast its presentation at the...

Genetic Engineering News:  Aug 28 2008 11:12AM
Matching: tab
Find similar documents
HTML
100%
Illumina to Present at Upcoming Investment Conferences in September
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc.

(NASDAQ:ILMN - News) today announced that the Company will webcast its presentations at two upcoming investment conferences in September 2008.

Illumina will webcast its presentation at the...

Yahoo!:  Aug 28 2008 10:01AM
Matching: tab
Find similar documents
HTML
100%
Government picks up health insurance tab
_ Government picks up health insurance tab.
AZCentral.com:  Aug 28 2008 8:21AM
Matching: tab
Find similar documents
HTML
100%
Nanosphere, Inc. to Present At the Thomas Weisel Partners Healthcare Conference 2008
NORTHBROOK, Ill., Aug.

26, 2008 (GLOBE NEWSWIRE) -- Nanosphere, Inc.

announced today that the company will present at the Thomas Weisel Partners Healthcare Conference 2008 taking place at the Four Seasons Hotel in Boston from September 3...

NewsBlaze:  Aug 26 2008 1:32PM
Matching: tab
Find similar documents
HTML
100%
Therapy for idiopathic GHD: take a break?
Some research has physicians questioning the concept of a trial off of GH therapy during childhood.

Print Email Discuss in our forum Since its approval in 1985, recombinant human growth hormone has been used to treat children with growth...

Endocrine Today:  Aug 25 2008 5:26PM
Matching: tab
Find similar documents
HTML
100%
K'taka drugs control faces acute shortage of inspectors
Karnataka Drugs Control Department has a shortfall of over 100 inspectors.

Currently, there are only 61 inspectors at the department out of the total requirement of 180.

According to Dr B R Jagashetty, drugs controller, Government of...

PharmaBiz:  Aug 23 2008 2:08PM
Matching: tab
Find similar documents
HTML
100%
King says Alpharma rebuffed a $1.4B buyout bid
King Pharmaceuticals Inc.

said Friday that rival Alpharma Inc.

has rejected a $1.4 billion buyout offer but indicated it is prepared to take the bid directly to shareholders in a move to expand its product offerings.

The Bristol, Tenn....

San Luis Obispo.com:  Aug 22 2008 7:07PM
Matching: tab
Find similar documents
HTML
100%
Aurobindo Pharma Receives Tentative Approval From US FDA For Losartan Potassium Tabs
Aurobindo Pharma said that the company received tentative approval to manufacture and market Losartan Potassium tablet from US Food & Drug Administration.

Losartan Potassium tablets are generic equivalent of Merck Research Laboratories...

Nasdaq:  Aug 21 2008 6:59AM
Matching: tab
Find similar documents
HTML
100%
Aurobindo Pharma gets initial US nod for losartan tabs
MUMBAI (Reuters) - Drugmaker Aurobindo Pharma Ltd said on Thursday it received a tentative approval from the U.S.

Food and Drug Administration for its generic losartan potassium tablets in multiple strengths.

The drug is the generic...

Therapeutics Daily:  Aug 21 2008 3:14PM
Matching: tab
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.